Sponsored by:

Molecular Imaging: Page 454

ImaRx wins NIH study grant
By AuntMinnie.com staff writers
Biopharmaceutical company ImaRx Therapeutics of Tucson, AZ, has received a grant from the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health (NIH).
August 22, 2007
DraxImage, Med Discovery team up
By AuntMinnie.com staff writers
Canadian radiopharmaceutical firm DraxImage and biological drug discovery company Med Discovery have formed a research collaboration.
August 22, 2007
PET exposes shift in brain function among young alcohol abusers
By Edward Susman
SAN FRANCISCO - Keggers and beer bongs may be a ubiquitous part of a young man's college experience, but even such short-term heavy drinking can cause significant neurological changes, according to a presentation last week at the American Psychological Association (APA) meeting. Researchers used FDG-PET imaging to detect changes in brain function among young male alcohol abusers.
August 22, 2007
PET/CT shows great sensitivity, concordance with soft-tissue sarcoma
By Wayne Forrest
Two studies on soft-tissue sarcoma show that PET/CT has a high sensitivity in initial staging and recurrence assessment, and a strong concordance between the two modalities in evaluating sarcoma lesions.
August 22, 2007
Prepping for CIIP exam; shortage of Ceretec agent
By Brian Casey
August 20, 2007
GE warns of impending Ceretec shortage
By AuntMinnie.com staff writers
Bad weather and flooding have forced Chalfont St. Giles, U.K.-based GE Healthcare to close its manufacturing facility in Gloucester, U.K., temporarily interrupting supplies of an imaging radiopharmaceutical.
August 20, 2007
IBA buries proton hatchet with Optivus, Loma Linda
By AuntMinnie.com staff writers
Belgian radiopharmaceutical firm Ion Beam Applications (IBA) of Louvain-la-Neuve has settled a patent infringement suit with Optivus Proton Therapy and Loma Linda University Medical Center, both of Loma Linda, CA.
August 20, 2007
Fused MRI and PET improve specificity of breast MRI
By Wayne Forrest
Researchers at New York University's School of Medicine have found that the combination of functional information from F-18 FDG-PET and anatomic localization from MR imaging can provide a valuable diagnostic method for the detection of primary and recurrent breast cancer. The study noted that fused PET and MRI images substantially increased the specificity of MRI, but, at the same time, decreased MRI's sensitivity in the group of patients analyzed.
August 16, 2007
2007 08 16 14 27 30 706
Molecular Insight appoints CFO
Molecular Insight Pharmaceuticals of Cambridge, MA has appointed a new chief financial officer.
August 15, 2007
Radiopharma recovery leads Covidien's imaging results
By AuntMinnie.com staff writers
Strong improvements in sales of its radiopharmaceutical products helped Covidien's imaging solutions business grow its sales by 5% in the third quarter of fiscal 2007 (end-June 30), the company's first quarterly reporting period since being spun off from Tyco International.
August 13, 2007
Breast gamma imaging spots DCIS better than mammo, MR
By Shalmali Pal
A dedicated breast gamma camera beat both mammography and MRI for the detection of ductal carcinoma in situ (DCIS), posting higher sensitivity ratings, according to a new study by Washington, DC, researchers. The study could add further fuel to the growing debate over the best modality to use when working up suspicious lesions detected on screening mammography.
August 12, 2007
Cardinal hires Philips executive
Healthcare products firm Cardinal Health of Dublin, OH, has named a former executive from Philips Medical Systems of Andover, MA, as executive vice president of strategy and corporate development.
August 12, 2007
Previous Page
Page 454 of 611
Next Page